Stay updated on Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the revision tag from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T10:30:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Show glossary was added; capitalization tweaks in labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; and a new 'Revision: v3.4.0' note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:23:53.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows an updated revision label, changing from v3.3.3 to v3.3.4. No study content, eligibility criteria, outcomes, or links are modified by this change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:12:33.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Locations section updated with new site listings across multiple states and a page revision (v3.3.3). This changes which trial sites are displayed to users.
    Difference
    0.8%
    Check dated 2025-12-23T22:04:09.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Publications section wording was updated to state that PubMed publications are automatically filled from PubMed and may not all pertain to the study, and the revision tag now shows Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:44.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Removed the government funding status notice; the rest of the page content and study data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:21:55.000Z thumbnail image

Stay in the know with updates to Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page.